CUREvsIBRN
DIREXION DAILY HEALTHCARE BULL 3X SHARES against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| CURE | IBRN | |
|---|---|---|
| Expense ratio | — | 0.47% |
| Assets | $175M | $6640.17T |
| Net flow, 1 month | −$7M | +$94K |
| Net flow, 1 year | −$90M | +$2M |
| Return, YTD | +16.1% | +0.7% |
| Return, 1 year | +42.8% | +18.6% |
| Avg daily volume | 46K | 2K |
| Holdings | 65 | 54 |
| Listed | May 2, 2024 | Aug 24, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS